From a total of 14173 patients with myeloid NGS performed from seven institutions, 170 patients with DNMT3A mutant chronic MNs (MDS, MDS/MPN and MPN) were identified, including 124 patients with MDS. Here, DNMT3A is linked to myeloproliferative neoplasm.